He has established several strong research programmes and platform technologies which focus on studying the molecular determinants for crosss-pecies transmission of avian influenza viruses and coronavirus. His research on influenza virus has led to important publications and the establishment of a unique DelNS1 live attenuated influenza vaccine system which has been used to develop vaccines for COVID-19, and become an important technology for the pandemic preparedness for future emerging respiratory viral diseases.